Autolus Therapeutics plc - ADR
AUTL
Get informed when a big investor buys or sells
+ FollowMarket Cap$401.88M
Close$
$-1.15
169.5% downside
Current Fair Value
169.5% downsideOvervalued by 169.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $401.88 Million |
|---|---|
| Enterprise Value | $350.91 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.08 |
| Beta | 2.01 |
| Outstanding Shares | 266,143,425 |
Return
| Return on Equity | -265.41% |
|---|---|
| Return on Assets | -54.80% |
| Return on Invested Capital | -56.32% |
Valuation & Multiples
| P/E Ratio | -1.39 |
|---|---|
| PEG | -67.64 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.79 |
| Enterprise Value to EBIT | -1.34 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.73 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$26.27 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$30.46 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 13.85% |
|---|---|
| Total Calls | 338,700▲ 369.11% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 50.51%▼ 1.81% |
|---|---|
| Total Invested | $184.35M▼ 33.42% |
| Investors Holding | 87▼ 5.00% |
ESG Score
No data